[Analysis of respiratory syncytial virus nonstructural protein 1 amino acid variation and clinical characteristics]

Objective: To investigate the relationship between amino acid variations of respiratory syncytial virus (RSV) nonstructural protein (NS) 1 and the clinical characteristics. Method: A retrospective case review was conducted. From December 2018 to January 2020, a total of 81 cases of hospitalized children who were tested only positive for RSV by RT-PCR or PCR at the Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University were included in the study. The NS1 genes of RSV subtype A and subtype B were amplified by PCR and sequenced. The amino acid sequences were analyzed. The Chi-square test and Mann-Whitney rank sum test were used to compare the clinical characteristics and type Ⅰ interferon levels of children with or without NS1 variation in the variation and non-variation groups. Results: Among 81 cases, there were 58 males and 23 females. There were 11 cases in the variation group, the age of onset was 2.0 (1.0, 11.0) months, included 4 cases of subtype A (variant sites were: 2 cases for Lys33Gln, one case for Gly2Asp, Pro67Ser, Leu137Phe, respectively) and 7 cases of subtype B (variant sites were: two cases for Val121Ile, one case for Tyr30Cys, Val65Met, Asn85Ser, Ser118Asn, Asp124Asn, respectively). These variant sites all appeared at a very low frequency 0.08 (0.04, 0.29) % in the NCBI PROTEIN database. There were 70 cases in non-variation group, the onset age was 3.5 (1.0, 7.0) months. The proportion of dyspnea in the variation group was higher than that in the non-variation group (10/11 vs. 47% (33/70), χ²=7.31, P<0.01). Conclusions: There are some variant sites in nonstructural protein NS1 of RSV. Children may be prone to have dyspnea with NS1 variations.

Abstract 5637: Path to the holy grail of spatial biology: Spatial single-cell whole transcriptomes using 6000-plex spatial molecular imaging on FFPE tissue

Cancer research across drug development, molecular biomarkers, and patient response depends on understanding biology that is dependent on complex interactions between malignant, immune, and stromal cells. To survive clearance mechanisms, a tumor can rely on a myriad of escape strategies, and the microenvironment is architected around the current path of escape. To enable a more comprehensive picture of tumor biology, we have developed the CosMx™ Spatial Molecular Imager (SMI) technology to capture a snapshot of thousands of RNA species resolved subcellularly from a single, standard histopathology slide. Building upon the previously released panels, this study tests a new 6,000-plex panel, the highest RNA plex measured in situ within human tissue, allowing the imputation of a spatial whole transcriptome in the tissue. We performed an ultra-high-plex RNA assay to detect 6,000 targets simultaneously in situ on an FFPE human liver cancer tissue (~1 cm2 area) using the CosMx SMI. This RNA panel covers broad biological areas with special emphasis on oncology, immunology, and signal transduction, such that all cancer researchers can benefit from the direct detection of targets of interest (sans imputation) in intact tissue. Analysis algorithms were developed to allow robust assessments of cell types, cell states, cell-cell interactions, and pathway activation. Imputation based on reference profiles from HCA, TCGA, and other public repositories allows estimation of non-measured transcripts at a ratio of approximately 1:3, compared to the approximate 1:20-1:70 imputations performed previously for spatial data.Thousands of transcripts were simultaneously detected with high sensitivity and specificity on the FFPE liver cancer tissue section at single-cell subcellular resolution. We were able to accurately map known reference profiles from scRNA-seq into this sample while identifying cancer-specific malignant, immune, and stromal cells in this tissue sample using this ultra-high plex RNA panel. In addition, we constructed sample-specific spatial neighborhoods, defined by cell types, cell states, and nearly unlimited sets of biological pathways through the imputed whole transcriptome. Finally, we measured &gt;1,000 ligand-receptor interactions between key cell types of adjacent cells in the tissue, identifying mechanisms for tumor-mediated escape as well as reactive re-architecting of the native stroma which defines the trajectory of cancer’s evolution. Single-cell spatial measurements of gene expression at 6,000 plex from a single FFPE slide has the potential to transform our understanding of tumor biology and facilitate the next advances in cancer research by extracting the highest data density possible from rare specimens collected during patient treatment.

Citation Format: Shanshan He, Michael Patrick, Jason W. Reeves, Patrick Danaher, Julian Preciado, Joseph Phan, Erin Piazza, Zachary Reitz, Lidan Wu, Rustem Khafizov, Haiyan Zhai, Michael Rhodes, David Ruff, Joseph Beechem. Path to the holy grail of spatial biology: Spatial single-cell whole transcriptomes using 6000-plex spatial molecular imaging on FFPE tissue. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5637.

[Metagenomic sequencing for diagnosis of sparganosis mansoni: a case report]

The patient was found to develop a migrating mass in the lower abdomen without any known cause in 2000, and the cause had not been identified following multiple diagnoses since then. The mass was found to migrate to the left anterior axillary regions on August 11, 2020. Then, three segments of incomplete white worms were resected through minimally invasive surgery, and metagenomic sequencing revealed sparganosis mansoni. After surgical resection of complete worms was performed on October 21, 2021, the case was cured and discharged from the hospital. Follow-up revealed satisfactory outcomes and no new mass was found throughout the body.

Hsa_circ_0011946 promotes the migration and invasion of hepatocellular carcinoma by inducing EMT process

OBJECTIVE

Recently, the vital role of circular RNAs is discovered in many diseases including tumor progression and metastasis. Hepatocellular carcinoma (HCC) is one of the most ordinary malignant tumors. The purpose of our study is to detect the potential function of hsa_circ_0011946 in HCC to offer new biomarkers and targets.

PATIENTS AND METHODS

The level of hsa_circ_0011946 in HCC tissues and cell lines was monitored by Real Time Quantitative Polymerase Chain Reaction (RT-qPCR). Pearson's Chi-square test was used to determine the association between hsa_circ_0011946 expression and several clinicopathological factors. Then, hsa_circ_0011946 was knocked down in HCC cells to uncover its function in metastasis of HCC. Cell migrated and invaded ability was measured through transwell assay, Matrigel assay and wound healing assay. Western blot assay was performed to analyze the effect of hsa_circ_0011946 on the epithelial-to-mesenchymal transition (EMT) process.

RESULTS

In this research, the expression level of hsa_circ_0011946 was significantly increased in HCC tissues compared to that in adjacent samples. The expression of hsa_circ_0011946 was also increased in HCC cell lines. The hsa_circ_0011946 expression was associated with lymphatic metastasis in HCC patients. Knockdown of hsa_circ_0011946 led to the inhibition of cell migration and invasion in HCC. In addition, results of further experiments revealed that the EMT-related proteins were regulated via the knockdown of hsa_circ_0011946 in HCC.

CONCLUSIONS

The hsa_circ_0011946 could enhance cell migration and invasion of HCC by inducing the EMT process.

MicroRNA-124 Enhances Dopamine Receptor Expression and Neuronal Proliferation in Mouse Models of Parkinson's Disease via the Hedgehog Signaling Pathway by Targeting EDN2

Recent studies have elaborated on the concept that a number of microRNAs (miRNAs) have a potential effect on the pathogenesis and development of Parkinson's disease (PD). PD is recognized as a common progressive bradykinetic disorder that results from the death of dopaminergic neurons in the substantia nigra. The purpose of this study was to explore whether microRNA-124 (miR-124) affected dopamine receptor (DAR) expression and neuronal proliferation and apoptosis in the 1-methyl-4-pheny-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse models of PD. The targeting relationship of miR-124 and EDN2 was confirmed through bioinformatic predictions and dual-luciferase reporter assay. The expression of miR-124 and EDN2 was altered to assess their effect on the expression of DAR in the substantia nigra and isolated neurons, as well as the neuronal proliferation and apoptosis rate. The obtained results implied that the treatments of miR-124 mimic and si-EDN2 resulted in elevated expressions of Glil, SHH, PTCH1, DAT, DRD1, and DRD2. However, these treatments facilitated neuronal proliferation and suppressed neuronal apoptosis, corresponding to reduced expression of caspase-3 and Bax, as well as increased levels of Bcl-2 expression. These results were discovered to be achieved through the activation of the Hedgehog signaling pathway. With this taken into account, our study demonstrated that miR-124 overexpression promoted DAR expression and neuronal proliferation and suppressed neuronal apoptosis by downregulating EDN2 via activating the Hedgehog signaling pathway.

Chalcogen-substitution modulated supramolecular chirality and gas sensing properties in perylenediimides

The supramolecular helicity and gas response of perylene dyes can be well modulated by chalcogen atoms in the perylene core.

Is lower low-density lipoprotein cholesterol associated with lower androgen and erectile dysfunction in men?

BACKGROUND AND AIMS

Therapeutic possibilities now exist to lower low-density lipoprotein cholesterol (LDL-C) to very low levels. However, substantial controversy remains in clinical practice with regard to its safety, and the question of whether low LDL-C levels per se may provoke adverse effects in humans arises. We aimed to explore the association of LDL-C with androgen and erectile dysfunction (ED) in a general population of men.

METHODS AND RESULTS

A total of 4203 men without hormone replacement therapy were enrolled from 22 sites in East China. Total testosterone (T) and Free T were assessed. Free androgen index (FAI) was calculated. The IIEF-5 questionnaire was used to assess ED. We found that free T and FAI gradually and markedly increased with increasing LDL-C levels. Using linear regression, after adjusting for age, educational level, economic status, smoking status, drinking status, BMI, diabetes, and use of lipid-lowering medication, LDL-C was positively associated with free T (B = 0.175, 95% CI: 0.084, 0.266) and FAI (B = 0.064, 95% CI: 0.016, 0.112). Meanwhile, there was a U-shaped curvilinear relationship between LDL-C and prevalence of ED. In the logistic regression analysis, compared to those with LDL-C among the 10th-90th percentile, the ORs of ED in men in the lowest and highest deciles were 1.938 (95% CI: 1.121, 3.349) and 1.804 (95% CI: 1.117, 2.916), respectively.

CONCLUSION

Lower LDL-C levels were significantly associated with lower free T and lower FAI in a general population of men. Moreover, both low and high levels of LDL-C might be risk factors for ED.

Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells

The biology of tumor-associated stroma (TAS) in pancreatic ductal adenocarcinoma (PDAC) is not well understood. The paradoxical observation that stroma-depletion strategies lead to progression of PDAC reinforced the need to critically evaluate the functional contribution of TAS in the initiation and progression of PDAC. PDAC and TAS cells are unique in their expression of specific miRNAs, and this specific miRNA expression pattern alters host to tumor microenvironment interactions. Using primary human pancreatic TAS cells and primary xenograft PDAC cells co-culture, we provide evidence of miRNA trafficking and exchanging between TAS and PDAC cells, in a two-way, cell-contact independent fashion, via extracellular vesicles (EVs) transportation. Selective packaging of miRNAs into EVs led to enrichment of stromal specific miR-145 in EVs secreted by TAS cells. Exosomes, but not microvesicles, derived from human TAS cells demonstrated a tumor suppressive role by inducing PDAC cell apoptosis. This effect was mitigated by anti-miR-145 sequences. Our data suggest that TAS-derived miRNAs are delivered to adjacent PDAC cells via exosomes and suppress tumor cell growth. These data highlight that TAS cells secrete exosomes carrying tumor suppressive genetic materials, a possible anti-tumor capacity. Future work of the development of patient-derived exosomes could have therapeutic implications for unresectable PDAC.

A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization

Renal cell carcinoma (RCC) constitutes an array of morphologically and genetically distinct tumors the most prevalent of which are clear cell, papillary, and chromophobe RCC. Accurate distinction between the typically benign-behaving renal oncocytoma and RCC subtypes is a frequent challenge for pathologists. This is critical for clinical decision making. Subtypes also have different survival outcomes and responses to therapy. We extracted RNA from ninety formalin-fixed paraffin-embedded (FFPE) tissues (27 clear cell, 29 papillary, 19 chromophobe, 4 unclassified RCC and 11 oncocytomas). We quantified the expression of six miRNAs (miR-221, miR-222, miR-126, miR-182, miR-200b and miR-200c) by qRT-PCR, and by in situ hybridization in an independent set of tumors. We developed a two-step classifier. In the first step, it uses expression of either miR-221 or miR-222 to distinguish the clear cell and papillary subtypes from chromophobe RCC and oncocytoma (miR-221 AUC: 0.96, 95% CI: 0.9132-1.014, p < 0.0001 and miR-222 AUC: 0.91, 95% CI: 0.8478-0.9772, p < 0.0001). In the second step, it uses miR-126 to discriminate clear cell from papillary RCC (AUC: 1, p < 0.0001) and miR-200b to discriminate chromophobe RCC from oncocytoma (AUC: 0.95, 95% CI: 0.8933-1.021, p < 0.0001). In situ hybridization showed a nuclear staining pattern. miR-126, miR-222 and miR-200b were significantly differentially expressed between the subtypes by in situ hybridization. miRNA expression could distinguish RCC subtypes and oncocytoma. miRNA expression assessed by either PCR or in situ hybridization can be a clinically useful diagnostic tool to complement morphologic renal tumor classification, improving diagnosis and patient management.

Abstract 5447: A microRNA signature for the classification of renal cell carcinoma subtypes

Introduction: Renal cell carcinoma (RCC) accounts for 90% of all kidney cancers. It comprises a heterogeneous group of renal tumors with distinct genetic and molecular characteristics including

clear cell RCC (ccRCC), papillary RCC (pRCC) and chromophobe RCC (chRCC). The differential diagnosis of RCC subtypes relies on distinct morphology which is not always accurate. Accurate classification of RCC subtypes is critical since each exhibits different clinical behaviour, prognosis and response to therapy. The purpose of this study is to determine whether a limited number of

miRNAs can classify RCC subtypes with high accuracy.

Experimental Design: We extracted RNA from 90 formalin-fixed paraffin-embedded (FFPE) tissues including 27 clear cell RCC, 29 papillary RCC, 19 chromophobe RCC, 4 unclassified RCC tumors and 11 oncocytomas. We measured the absolute expression of six miRNAs by qRT-PCR. Receiver operator characteristic curves were constructed and the area under the curve (AUC) was calculated to assess diagnostic performance. We also tested miRNA expression by in situ hybridization (ISH) in an independent set of ninety-eight FFPE renal tumors.

Results: We developed a two-step miRNA classifier. In the first step, expressions of selected miRNAs were found to discriminate clear cell RCC and papillary RCC from chromophobe RCC and renal oncocytoma. Two miRNAs were able to discriminate clear cell RCC and papillary RCC from chromophobe RCC and oncocytoma. miR-221 was significantly overexpressed in chromophobe RCC and oncocytoma compared to clear cell RCC and papillary RCC (4.49-fold change, p= 6.398e-010) and was able to discriminate between the two groups (AUC: 0.9637, 95% CI: 0.9132 to 1.014, p&lt;0.0001). In the second step, the absolute expression of two miRNAs could distinguish clear cell RCC from papillary RCC (10.4-fold change, p = 1.243e-013). Moreover, an additional two miRNAs could differentiate chromophobe RCC from renal oncocytoma (3.30- fold change, p = 1.751e-006). In situ hybridization revealed that miRNAs display a nuclear staining pattern that was able to distinguish clear cell RCC from papillary RCC (p&lt;0.001) and chromophobe RCC from renal oncocytoma (p =0.009).

Conclusion: miRNA expressions were able to distinguish between RCC subtypes and renal oncocytoma. miRNA assessment by in situ hybridization is a clinically useful diagnostic tool that can complement current methods for RCC classification.

Citation Format: Ashley Di Meo, Mereet Hanna, Rola Saleeb, Samantha Wala, Adriana Krizova, Manal Gabril, Haiyan Zhai, Maria Pasic, Andrew Evans, Fadi Brimo, George Yousef. A microRNA signature for the classification of renal cell carcinoma subtypes [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 5447. doi:10.1158/1538-7445.AM2017-5447

Abstract P1-03-10: HER2 expression in clinical breast cancer samples: A novel detection methodology for HER2 protein quantitation using fluorescent nanoparticles

Background: The human epidermal growth factor receptor-2 (HER2) is a member of a family of transmembrane tyrosine kinase receptors that play an important role in regulated normal cell growth and differentiation. The over-expression of HER2 in a subset of 15-20% of invasive breast cancers has an important bearing on prognosis, as HER2-positive tumors are associated with an aggressive clinical course and poor outcome. Targeting HER2-overexpression has been shown to be a remarkably effective therapeutic modality; however testing of tumor samples to assess the HER2 status of the patient's breast cancer is required. Clinical assays to assess the HER2 status in patients being considered for targeted therapy include immunohistochemistry (IHC), which detects protein over-expression, or fluorescence in situ hybridization (FISH), which detects gene amplification. Both the IHC and FISH methodologies have limitations. Given that the target of the currently approved drugs is the receptor protein, novel detections systems that could more accurately and quantitatively detect HER2 protein in clinical samples over a broad dynamic range would be advantageous and may be clinically helpful.

Material and Methods: A novel detection technology using streptavidin-coated Phosphor Integrated Dot fluorescent nanoparticles (PID) has been developed that can be visualized by fluorescence microscopy and used for quantitative immunofluorescence detection of protein in clinical samples using computer assisted image analysis. In the current study, PID- nanoparticles were used to analyze HER2 protein expression in breast cancer cell lines and 120 well characterized breast cancer samples. These results have been compared with HER2 IHC and HER2 FISH analysis.

Results: The expression levels of HER2 protein from 8 breast cancer cell lines was evaluated by antibody-binding capacity with FACS analysis. Formalin fixed paraffin embedded cell pellets for these cell lines were prepared and used for quantitative HER2 analysis by PID. The PID score/cell for each of these cell lines showed a strong linear correlation with antibody-binding capacity sites/cell by FACS analysis (R2 = 0.94). For the 120 breast cancer samples, PID score/cell was measured and compared against HER2 IHC membrane intensity measure by image analysis (Aperio) and HER2 FISH results. The HER2 PID score/cell showed a correlation coefficient of R2=0.72 versus the average HER2 copy number per cell by FISH, compared with a correlation coefficient of R2=0.41 for HER2 IHC membrane intensity measured by Aperio. For the HER2/CEP17 ratio, the correlation coefficient for the PID score/cell was R2=0.79 compared with a correlation coefficient of R2=0.32 for the HER2 IHC membrane intensity.

Conclusions: PID-nanoparticles demonstrate great potential for the quantitative measurement of protein of clinical interest in routine clinical samples with morphologic confirmation of the tissue being studied. Further studies looking for PID-score thresholds for HER2 gene amplification and correlations with clinical outcome data are warranted and ongoing.

Citation Format: Hicks DG, Goda H, Zhai H, Okada H, McMahon L, Sullivan N, Tang P, Nakano Y. HER2 expression in clinical breast cancer samples: A novel detection methodology for HER2 protein quantitation using fluorescent nanoparticles [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P1-03-10.

Abstract 1968: Systematic validation of microRNA based prognostic biomarkers for stage II, III and IV colorectal cancer

microRNA (miRNA) based biomarkers have great potential due to their critical regulatory functions, superior stability, and relative small number compared to mRNAs. We have previously discovered a number of miRNAs that play key roles in colon cancer stem cell resistance and demonstrated their clinical potential as prognostic biomarkers. In this study, we have validated the prognostic potential of a panel of miRNAs in 204 stage II, III, and IV colorectal cancer specimens by qRT-PCR analysis. Many of the miRNAs have been functionally validated to be important in contributing to chemoresistance to 5-FU based chemotherapy. We also determined that miR-16 is the most consistent miRNA for expression normalization. We have validated several miRNAs that are significantly associated with disease free survival (DFS) and overall survival (OS) of stage II, III and IV colorectal cancer patients. This study, together with some of the previous studies, establishes a solid foundation for miRNA based precision management of colorectal cancer.

Citation Format: Dongling Ma, Yaqi Xue, Andrew Fesler, Haiyan Zhai, Jie Yang, Apisri Ieamniramit, Wenzhe Li, Jingfang Ju. Systematic validation of microRNA based prognostic biomarkers for stage II, III and IV colorectal cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1968.

True digestible phosphorus requirement for forty- to eighty-kilogram pigs

The objective of this study was to determine the true digestible P requirement of 40- to 60-kg (Exp. 1) and 60- to 80-kg (Exp. 2) pigs by broken-line analysis of growth performance data using 6 levels of true digestible P. In each 3-wk experiment, 108 barrows and gilts were used, and 6 levels of monocalcium phosphate were added to a corn-soybean meal-based diet to establish 6 graded levels of true total tract digestible P ranging from 1.26 to 3.98 g/kg of diet in Exp. 1 or from 1.21 to 3.31 g/kg in Exp. 2. The true digestible P content was calculated using true total tract digestibility of 40.53%, 35.96%, and 84.31% for P in corn, soybean meal, and monocalcium phosphate, respectively. Limestone was added accordingly to maintain a constant Ca level across all diets of each experiment. The results of Exp. 1 showed that with graded supplementation of monocalcium phosphate, ADG linearly increased ( < 0.001) in wk 1 and both linearly and quadratically increased ( < 0.01) in wk 2, wk 3, and wk 0 to 3, and G:F linearly improved ( < 0.001) in wk 1, quadratically improved ( < 0.05) in wk 3, and both linearly and quadratically improved ( < 0.05) in wk 2 and wk 0 to 3 ( < 0.05). In Exp. 2, ADG linearly increased ( < 0.001) in wk 1 and both linearly and quadratically increased ( < 0.05) in wk 2, wk 3, and wk 0 to 3, with the graded supplementation of monocalcium phosphate, and G:F linearly improved ( < 0.01) in wk 1 and wk 3 and both linearly and quadratically improved ( < 0.001) in wk 2 and wk 0 to 3. In Exp. 1, the true digestible P requirement was estimated to be 2.66, 2.79, and 2.51 g/kg of diet (884 g DM/kg) for pigs of mixed sex, barrows, and gilts, respectively, on the basis of broken-line regression of ADG data for wk 0 to 3 against 6 true digestible P levels. Using G:F, the P requirement estimate was correspondingly 2.67, 2.51, and 2.93 g/kg of diet. In Exp. 2, the true digestible P requirement was estimated to be 2.29, 2.20, and 2.39 g/kg of diet (884 g DM/kg) using ADG data for wk 0 to 3 as the response variable and to be 2.33, 2.19, and 2.47 g/kg using wk 0 to 3 G:F data for pigs of mixed sex, barrows, and gilts, respectively. In conclusion, the mean TTTD-based P requirement was 2.66 and 2.31 g/kg of diet (884 g DM/kg) for 40- to 60-kg and 60- to 80-kg pigs, respectively.

Abstract 3117: Hsa-miR-140-5p inhibits colorectal cancer stem cell invasion and metastasis by suppressing Smad2 and autophagy

Colorectal cancer is one of the most common cancers and frequently metastasizes to the liver. TGF-β signaling has been shown to regulate cancer metastasis by promoting epithelial to mesenchymal transition and cancer stem cell (CSC) phenotypes. Smad2 is a key element downstream of TGF-β. In this study, we showed that hsa-hsa-miR-140-5p-5p directly targets Smad2 and overexpression of hsa-miR-140-5p in colorectal cancer cell lines decreases Smad2 expression level, which leads to decreased level of cell invasion and proliferation, as well as increasing cell cycle arrest. Ectopic expression of hsa-miR-140-5p in colorectal CSCs inhibited CSC growth and sphere formation in vitro by disrupting autophagy, an essential process for cancer cell survival and chemoresistance. We have systematically identified the targets of hsa-miR-140-5p involved in autophagy. Furthermore, overexpression of hsa-miR-140-5p in CSCs abolished the tumor formation as well as metastasis in vivo by using subcutaneous xenografts and tail vein injection of CSCs in NOD/SCID mice. In addition, there is a progressive loss of hsa-miR-140-5p expression from normal colorectal mucosa to primary tumor tissues, with further reduction in liver metastatic tissues, quantified by qRT-PCR. The functional and clinical significance of hsa-miR-140-5p suggests that it is a key regulator in colorectal cancer progression and metastasis. As a result, it may have potential as a novel therapeutic molecule to treat colorectal cancer.

Citation Format: Haiyan Zhai, Andrew Fesler, Jingfang Ju. Hsa-miR-140-5p inhibits colorectal cancer stem cell invasion and metastasis by suppressing Smad2 and autophagy. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3117. doi:10.1158/1538-7445.AM2015-3117

Abstract 3079: Mechanism of hsa-miR-15a in EMT and chemoresistance in colorectal cancer

Epigenetic alterations such as non-coding microRNAs are critical factors in EMT and chemoresistance. Hsa-miR-15a, as one of the first miRNA identified to be associated with cancer, has been investigated for its role in several types of cancer. We are interested in understanding the molecular and cellular mechanism of hsa-miR-15a in colorectal cancer as hsa-miR-15a is down-regulated in colon cancer and associated with poor patient prognosis. In this study, we have identified several direct key targets of hsa-miR-15a that impact EMT transition, cell cycle and apoptosis. Our results show that the expression of BMI-1, an important regulator of EMT, was suppressed by hsa-miR-15a. The reduction of hsa-miR-15a in colorectal cancer patient samples was significantly inversely correlated with BMI-1 over-expression. Hsa-miR-15a also suppresses the expression of anti-apoptotic protein BCL-2. The suppression of BMI-1, BCL-2 as well as other key targets by hsa-miR-15a has potential for increasing chemosensitivity as well as disrupting cancer stem cell self renewal. In addition, hsa-miR-15a also has potential as a prognostic biomarker in colorectal cancer. This work will provide a further understanding of the mechanism of hsa-miR-15a loss in colorectal cancer and its clinical significance in relationship with its targets and pathways. The functional significance of hsa-miR-15a in regulating key targets and pathways establishes the foundation for hsa-miR-15a as a potential novel therapeutic strategy for treating colorectal cancer.

Citation Format: Andrew Fesler, Haiyan Zhai, Jingfang Ju. Mechanism of hsa-miR-15a in EMT and chemoresistance in colorectal cancer. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3079. doi:10.1158/1538-7445.AM2015-3079

Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors

The histone methyltransferase Enhancer of Zeste Homolog 2 (EZH2) is frequently dysregulated in cancers, and gain-of-function (GOF) EZH2 mutations have been identified in non-Hodgkin lymphomas. Small-molecule inhibitors against EZH2 demonstrated anti-tumor activity in EZH2-mutated lymphomas and entered clinical trials. Here, we developed models of acquired resistance to EZH2 inhibitor EI1 with EZH2-mutated lymphoma cells. Resistance was generated by secondary mutations in both wild-type (WT) and GOF Y641N EZH2 alleles. These EZH2 mutants retained the substrate specificity of their predecessor complexes but became refractory to biochemical inhibition by EZH2 inhibitors. Resistant cells were able to maintain a high level of H3K27Me3 in the presence of inhibitors. Interestingly, mutation of EZH2 WT alone generated an intermediate resistance phenotype, which is consistent with a previously proposed model of cooperation between EZH2 WT and Y641N mutants to promote tumorigenesis. In addition, the findings presented here have implications for the clinical translation of EZH2 inhibitors and underscore the need to develop novel EZH2 inhibitors to target potential resistance emerging in clinical settings.

Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients

Early detection of colorectal cancer (CRC) is key for prevention and the ability to impact long-term survival of CRC patients. However, the compliance rate of recommended colonoscopy for the population aged from 50 to 75 years is only 50-75 % in the US. A highly sensitive and specific non-invasive test is needed to enhance CRC management. As for late-stage patients, a non-invasive prognostic biomarker is also critical for improving patient treatment protocols. The discovery that non-coding microRNAs (miRNAs) are stable in body fluids such as plasma, serum and exosomes presents the opportunity to develop novel strategies, taking advantage of circulating miRNAs as early diagnostic biomarkers of CRC. The goal of using circulating miRNA-based prognostic biomarkers for CRC patients has been pursued extensively. In this review, we will try to cover the major recent advancements at the frontier of this research area.

Abstract PR13: Using a hypoxia-induced CSC tumor initiation model to improve predictive potential for patients with metastatic breast cancer

About 10-20% of breast cancers are found to be triple-negative. TNBCs have a relapse pattern that is very different from hormone-positive breast cancers: the risk of relapse is much higher for the first 3-5 years but drops substantially below that of hormone-positive breast cancers after that. Therefore, preventing tumor recurrence and metastasis in high-risk TNBC patients within 3-5 years of diagnosis will dramatically improve the long-term survival of these patients. Currently, most of preclinical animal models have limited predictive clinical potential for advanced metastatic diseases. One possible explanation is that most of the pre-clinical studies focus on the therapeutic benefit of eradicating bulk tumor cells. Using a stem-like subpopulation from triple negative breast cancer (TNBC) cell lines enriched by exposing the cells to cycles of hypoxia and reoxygenation, we showed that mammary tumors initiated from this subpopulation have a high recurrence rate (100%) after the taxol treatment compared to no recurrence from taxol treated tumors initiated from the bulk cancer cells. Our model mimics the progression of recurrence-prone breast tumors with a period of dormancy before the recurrence of local and distal tumors. Molecular analysis of the treatment naïve and recurrent tumors revealed increased expression of chemoresistance-associated miRNAs in the recurred xenograft tumors. In addition, we identified new markers in the recurred xenograft tumors that are also increased in drug resistant human breast tumors compared to the treatment naïve breast tumors. Ultimately, we propose that cancer stem cell based tumor model can be used to improve the predictive potential of pre-clinical models for patients with metastatic breast tumors.

This abstract is also presented as Poster A12.

Citation Format: Purvi Patel, Yupo Ma, Haiyan Zhai, Jingfeng Ju, Emily Chen. Using a hypoxia-induced CSC tumor initiation model to improve predictive potential for patients with metastatic breast cancer. [abstract]. In: Proceedings of the AACR Special Conference: The Translational Impact of Model Organisms in Cancer; Nov 5-8, 2013; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Res 2014;12(11 Suppl):Abstract nr PR13.

Helical supramolecular aggregates of sugar-based perylene dyes: the effect of core-substituted groups

Here we have shown that it is possible to modulate π-π stacking, hydrogen bonds and hydrophobic and hydrophilic interactions to further adjust the supramolecular helicity by simply changing the core-substituted group. These modulated supramolecular interactions provide a new pathway to the controlled production of helical superstructures.

Gastroretentive extended-release floating granules prepared using a novel fluidized hot melt granulation (FHMG) technique

The objective of this work was to investigate the feasibility of using a novel granulation technique, namely, fluidized hot melt granulation (FHMG), to prepare gastroretentive extended-release floating granules. In this study we have utilized FHMG, a solvent free process in which granulation is achieved with the aid of low melting point materials, using Compritol 888 ATO and Gelucire 50/13 as meltable binders, in place of conventional liquid binders. The physicochemical properties, morphology, floating properties, and drug release of the manufactured granules were investigated. Granules prepared by this method were spherical in shape and showed good flowability. The floating granules exhibited sustained release exceeding 10 h. Granule buoyancy (floating time and strength) and drug release properties were significantly influenced by formulation variables such as excipient type and concentration, and the physical characteristics (particle size, hydrophilicity) of the excipients. Drug release rate was increased by increasing the concentration of hydroxypropyl cellulose (HPC) and Gelucire 50/13, or by decreasing the particle size of HPC. Floating strength was improved through the incorporation of sodium bicarbonate and citric acid. Furthermore, floating strength was influenced by the concentration of HPC within the formulation. Granules prepared in this way show good physical characteristics, floating ability, and drug release properties when placed in simulated gastric fluid. Moreover, the drug release and floating properties can be controlled by modification of the ratio or physical characteristics of the excipients used in the formulation.

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer

In the last decade, cancer research efforts in the field of noncoding microRNA (miRNA) have been growing exponentially. miRNA-based therapeutics have been tested in both preclinical and clinical settings, and miRNA-based cancer diagnostics and prognostics have moved into clinics to help better manage cancer treatment. A growing body of evidence in recent literature suggests miRNA-129 plays important roles in gastrointestinal cancer, including gastric, colorectal, hepatocellular carcinoma, and esophageal cancer. In this review, we focus on accumulating evidence demonstrating the key roles that miRNA-129 plays in tumorigenesis, disease progression, chemoresistance, proliferation, and cell cycle control. Understanding the emerging roles and mechanisms of miRNA-129 in cancer will help us realize the therapeutic and diagnostic/prognostic potential.

First Report of Fusarium equiseti Causing a Sheath Rot of Corn in China

Corn is the most important cereal crop in China. Over 34.94 million ha of corn is cultivated in the country annually. However, fungal diseases are a major limiting factor in corn production. In August 2008, 50 ha in several corn fields in Liaoning, Jilin, and Heilongjiang provinces were observed to be severely affected by a disease causing a yield loss of 30%. Results from field surveys suggested an epidemic during late corn growth stages that affected corn sheaths, causing irregularly circular spots with grayish brown to dark brown lesions. Lesions ranged from 2.5 to 3 × 3 to 5 cm. To isolate the causal agent, tissue was removed from the border of lesions and surface sterilized in 75% ethanol for 30 sec and 0.1% HgCl₂ for 1 min. The sample was then triple rinsed in sterile distilled water. The isolate was purified and subcultured on potato dextrose agar (PDA) at 25 ± 2°C. The initial color of the mycelium was white, turning brown after being cultured for 7 days. A pale brown to dark brown pigment developed in the agar beneath the colony. Chlamydospores, solitary but also in short chains, measuring 7.2 to 15.3 μm, were produced on carnation leaf agar (CLA) after 10 days and became verrucose 20 days later. Macroconidia were produced on CLA in orange sporodochia from monophialides on branched conidiophores, usually 5- to 7-septate, and apical cells were tapered and elongate. Basal cells were prominent, foot-shaped, and elongated in appearance. Microconidia were not observed (1). These morphological characteristics matched the description of Fusarium equiseti reported by Leslie and Summerell (1). A pathogenicity test was conducted with an isolate from each of the 36 corn plants by spraying 2 ml of spore suspension (10⁶ conidia/ml) on 45-day-old corn sheaths (cv. Huang Zao). For the control treatment, 36 corn plants were sprayed with an equal volume of sterilized water. Inoculated plants were placed in a greenhouse at 32 to 34°C and 95% relative humidity. Typical irregularly circular lesions were observed 7 days after inoculation, except in the control samples. Each treatment was replicated three times. The suspected pathogen was consistently re-isolated from diseased tissue according to Koch's postulates, and was found to be morphologically similar to F. equiseti. Preliminary morphological identification of the fungus was confirmed by a PCR assay using genomic DNA extracted from the mycelia of a 7-day-old culture on PDA at 25 ± 2°C. A 750-bp amplified region of the transcription elongation factor (TEF) of rDNA was generated using TEF1 (5'-ATGGGTAAGGAGGACAAGAC-3') and TEF2 (5'-GGAAGTACCAGTGATCATGTT-3') primers. The TEF region (GenBank Accession No. KF754798) was sequenced by Sangon Biotech Co., Ltd. (Shanghai, China) and displayed 99% nucleotide similarity with the rDNA-TEF of F. equiseti (JN127347.1) separately after a BLASTn search in GenBank. Based on the symptoms, fungal morphology, TEF sequence, and pathogenicity testing, this fungus was identified as F. equiseti. To our knowledge, this is the first report of F. equiseti on corn sheaths in China. This report will establish a foundation for further study of F. equiseti to address the disease effectively and to determine the severity of damage caused by F. equiseti. Reference: (1) J. F. Leslie and B. A. Summerell. The Fusarium Laboratory Manual. Blackwell, Ames, IA, 2006.

Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker

Most previously described immunohistochemical markers of cervical high-grade squamous intraepithelial lesion (HSIL) and squamous cell carcinoma may help to improve diagnostic accuracy but have a minimal prognostic value. The goals of the current study were to identify and validate novel candidate biomarkers that could potentially improve diagnostic and prognostic accuracy for cervical HSIL and squamous cell carcinoma. Microdissected tissue sections from formalin-fixed paraffin-embedded normal ectocervical squamous mucosa, low-grade squamous intraepithelial lesion (LSIL), HSIL and squamous cell carcinoma sections were analyzed by mass spectrometry-based shotgun proteomics for biomarker discovery. The diagnostic specificity of candidate biomarkers was subsequently evaluated by immunohistochemical analysis of tissue microarrays. Among 1750 proteins identified by proteomic analyses, keratin 4 (KRT4) and keratin 17 (KRT17) showed reciprocal patterns of expression in the spectrum of cases ranging from normal ectocervical squamous mucosa to squamous cell carcinoma. Immunohistochemical studies confirmed that KRT4 expression was significantly decreased in squamous cell carcinoma compared with the other diagnostic categories. By contrast, KRT17 expression was significantly increased in HSIL and squamous cell carcinoma compared with normal ectocervical squamous mucosa and LSIL. KRT17 was also highly expressed in immature squamous metaplasia and in endocervical reserve cells but was generally not detected in mature squamous metaplasia. Furthermore, high levels of KRT17 expression were significantly associated with poor survival of squamous cell carcinoma patients (Hazard ratio=14.76, P=0.01). In summary, both KRT4 and KRT17 expressions are related to the histopathology of the cervical squamous mucosa; KRT17 is highly overexpressed in immature squamous metaplasia, in HSIL, and in squamous cell carcinoma and the level of KRT17 in squamous cell carcinoma may help to identify patients who are at greatest risk for cervical cancer mortality.

Prognostic significance of miR-194 in endometrial cancer

Endometrial cancer (EC) is the leading malignant tumor occurring in the female genital tract and some subtypes are highly invasive and metastatic. miRNAs are small non-coding RNAs that have a broad impact on cancer progression. In particular, miR-194 regulates epithelial to mesenchymal transition (EMT) by suppressing the expression of BMI-1 in EC. In this retrospective study, the clinical significance of miR-194 was investigated in archival EC specimens. We extracted total RNA from thirty-two EC samples and quantified the expression level of miR-194. We discovered that the expression level of miR-194 was significantly (P = 0.03) lower in type I EC patients with more advanced stage. In addition, patients with higher miR-194 levels have better prognosis than those with lower miR-194 levels (P = 0.0067; Cut-off value of miR-194 = 0.3). These results indicate that miR-194 has potential to serve as prognostic biomarker for EC patients.

True digestible phosphorus requirement for twenty- to forty-kilogram pigs

The objective of this study was to determine the true digestible P requirements of 20- to 40-kg pigs by the broken-line regression analysis of growth performance using 6 levels of true total-tract digestible P. In Exp. 1, 24 barrows (initial BW=25.2±1.0 kg) were used to determine the true total-tract digestibility (TTTD) of P in monocalcium phosphate using the regression method. The dietary treatments included a corn-soybean meal-based diet (2.96 g total P/kg) and 3 additional dietary treatments with incremental addition of 0.50 g P/kg through monocalcium phosphate. Limestone (37.2% Ca) was added to maintain a constant Ca to P ratio of 1.25 to 1 across all diets. A 5-d adjustment period preceded a 5-d total collection of feces. Ferric oxide was used as a marker to time the initiation and termination of fecal collection. In Exp. 2, 108 barrows and gilts (initial BW=20.1±1.2 kg) were used in a 3-wk growth performance trial. Monocalcium phosphate was added to a corn-soybean meal-based diet to set up 6 levels of TTTD-based digestible P, ranging from 1.31 to 4.64 g/kg of diet with increments of 0.67 g/kg digestible P. Limestone was added to maintain a constant Ca level across all diets. The results of Exp.1 showed that dietary P intake, fecal P output, digested P, and apparent total-tract digestibility of P increased linearly (P<0.05) with the increasing supplementation of monocalcium phosphate. Regressing daily digested P against daily P intake resulted in TTTD of 84.3% for P in monocalcium phosphate. In Exp. 2, ADG, ADFI, and G:F increased both linearly (P<0.01) and quadratically (P<0.05) with increasing P level in wk 1 and 3 and for the overall 3-wk duration. In wk 2, both linear and quadratic effects of P level were observed for ADG and ADFI (P<0.05) whereas the G:F only showed linear improvement (P<0.01). The true digestible P requirement, defined as the breakpoint using the overall 3-wk G:F as the response variable, was estimated to be 3.03, 2.98, and 3.08 g/kg of diet for pigs of mixed sex, barrows, and gilts, respectively. Using ADG, the corresponding estimates of P requirement were 3.09, 3.08, and 3.10 g/kg of diet. In conclusion, the mean true digestible P requirement of pigs from 20 to 40 kg BW was determined to be 3.06 g/kg of diet using the average of the estimates for barrows and gilts based on ADG.

Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer

BACKGROUND

Long intergenic noncoding RNAs (lincRNAs) have been shown to be novel regulators for both transcription and posttranscriptional/translation. One of them, lincRNA-p21, was regulated by p53 and contributed to apoptosis in mouse embryonic fibroblasts. However, the impact of such regulation on colorectal cancer (CRC) remains to be determined.

METHODS

Total RNA was extracted from CRC cell lines and snap fresh frozen CRC samples from 2 CRC patient cohorts. The expression of lincRNA-p21 was quantified by quantitative real-time polymerase chain reaction analysis.

RESULTS

We discovered that the expression level of lincRNA-p21 was increased by elevated wild-type p53 induced by nutlin-3 in HCT-116 colon cancer cells. The expression level of lincRNA-p21 was significantly (P = .0208) lower in CRC tumor tissue when compared with the paired normal tissue from the same patient. There was no significant correlation of lincRNA-p21 with p53 status (wild-type vs. mutant). Tumors in the rectum showed a higher level of lincRNA-p21 than tumors in the colon (P = .00005). In addition, lincRNA-p21 in patients with stage III tumors was significantly higher than in those with stage I tumors (P = .007). Elevated levels of lincRNA-p21 were significantly associated with higher pT (P = .037 between pT 2 and 3) and vascular invasion (P = .017).

CONCLUSIONS

These results indicate that lincRNA-p21 may contribute to CRC disease progression.

True digestible phosphorus requirement of 10- to 20-kg pigs

The objective of this study was to determine the true digestible P requirement of 10- to 20-kg pigs by broken-line regression analysis of growth performance using 6 levels of true total-tract digestible P. In Exp. 1, 48 barrows were used to determine the true total-tract digestibility (TTTD) of P in monocalcium phosphate using the regression method. The dietary treatments included a negative control (3.30 g/kg total P) and 7 additional dietary treatments with incremental addition of 0.74 g/kg P through monocalcium phosphate, resulting in a dietary range of 3.30 to 8.45 g/kg total P. Limestone was added accordingly to maintain a constant Ca to P ratio of 1.25:1 across all diets. A 5-d adjustment period preceded a 5-d total collection of feces. Ferric oxide was used to time the initiation and termination of fecal collection. In Exp. 2, 108 barrows and gilts were used in a 3-wk growth performance study. Monocalcium phosphate was added to a corn-soybean meal-based diet to set up 6 levels of TTTD-based digestible P, ranging from 1.55 to 4.21 g/kg at an increment of 0.53 g/kg digestible P. Limestone was added accordingly to maintain a constant Ca level across all diets. The results of Exp.1 showed dietary P intake, fecal P output, and digested P increased linearly (P < 0.001) with the increasing P level, whereas the apparent total-tract digestibility of P increased both linearly and quadratically (P < 0.01). The regression of daily digested P against daily P intake gave a TTTD of 67.5% for P in monocalcium phosphate. In Exp. 2, ADG increased linearly (P < 0.001) with the increasing P level in wk 1. In wk 2, wk 3, and the overall 3-wk duration, both linear and quadratic effects of P level (P < 0.05) were observed for ADG. Average daily feed intake increased with the addition of monocalcium phosphate linearly in wk 2 (P < 0.05) and during the overall period (P < 0.001) and both linearly (P < 0.001) and quadratically (P < 0.05) in wk 3. For any period, the G:F was improved in both a linear (P < 0.001) and quadratic (P < 0.05) fashion. The true digestible P requirement, defined as the breakpoint using G:F of the overall duration, was estimated to be 3.22, 2.81, and 3.45 g/kg of diet with dietary DM averaged at 887 g/kg for pigs of mixed sex, barrows, and gilts, respectively. Using ADG, the corresponding P requirement was 3.19, 3.40, and 2.97 g/kg of diet. In conclusion, the true digestible P requirement of pigs from 10 to 20 kg BW was determined to be 3.2 g/kg of diet.

Abstract 1840: Clinical significance of lincRNA-p21 in colorectal cancer

Large Intergenic Noncoding RNAs (LincRNAs) have been recently shown to be novel regulators for both transcription and posttranscriptional/translation. One of them, lincRNA-p21, was regulated by p53 and contributed to apoptosis in mouse embryonic fibroblasts. However, the impact of such regulation on colorectal cancer (CRC) is remained to be determined. In this study, we discovered that the expression level of lincRNA-p21 was increased by elevated wild type p53 induced by Nutlin in HCT116 colon cancer cells. The clinical significance of lincRNA-p21 was further investigated in 2 CRC patient cohorts. The expression of lincRNA-p21 was quantified by the real time qRT-PCR analysis using total RNAs extracted from snap fresh frozen CRC samples. Our results reveal that the expression level of lincRNA-p21 is significantly (P = 0.0208) lower in CRC tumor tissue when compared to the paired normal tissue from the same patient. There is no significant correlation of lincRNA-p21 with p53 status (wild type vs. mutant). Tumors in rectum show higher level of lincRNA-p21 than the ones in colon (P = 0.00005). In addition, lincRNA-p21 in stage III patients was significantly higher than stage I patients (P = 0.007). Elevated level of lincRNA-p21 was significantly associated with higher pT (P = 0.037 between pT 2 and 3), and vascular invasion (P = 0.017). LincRNA-p21 was not significantly associated with patient's overall survival. These results indicate that lincRNA-p21 may contribute to CRC disease progression.

Citation Format: Haiyan Zhai, Andrew Fesler, Kristina Schee, Øystein Fodstad, Kjersti Flatmark, Jingfang Ju. Clinical significance of lincRNA-p21 in colorectal cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1840. doi:10.1158/1538-7445.AM2013-1840

Abstract 4185: miR-129 is a potential tumor suppressor in colorectal cancer by regulating apoptosis and modulating fluropyrimidine based chemosensitivity

Resistance to fluoropyrimidine based chemotherapy is the major reason for the failure of treating advanced colorectal cancer. The lack of ability for tumor cells to undergo apoptosis after genotoxic stress is the key contributor to such intrinsic mechanism. Mounting evidence has demonstrated that non-coding microRNAs (miRNAs) are crucial regulators of gene expression, in particular, under acute stress. However, there is still very limited knowledge about the role of miRNAs in apoptosis. In this study, we discovered a novel mechanism mediated by miR-129 directly inducing apoptosis by suppressing a key anti-apoptotic protein Bcl-2. Ectopic expression of miR-129 promotes apoptosis, inhibits cell proliferation and causes G2-cell-cycle arrest in colon cancer cells in vitro. The intrinsic apoptotic pathway triggered by miR-129 is activated by cleaving caspase-9 and caspase-3. The expression of miR-129 is very significantly down-regulated in colorectal cancer tissue specimens compared with the paired normal control samples (p&lt;0.00001). More importantly, we demonstrated that miR-129 functions synergistically with 5-fluorouracil (5-FU) in vitro and in vivo to enhance 5-FU cytotoxicity. These results suggest that miR-129 is a major regulator of apoptosis in colorectal cancer. Therefore, miR-129 may be a potential tumor suppressor in colorectal cancer and a novel candidate for developing miR-129 based therapeutic strategies.

Citation Format: Mihriban Karaayvaz, Haiyan Zhai, Jingfang Ju. miR-129 is a potential tumor suppressor in colorectal cancer by regulating apoptosis and modulating fluropyrimidine based chemosensitivity. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4185. doi:10.1158/1538-7445.AM2013-4185

Abstract 5293: Prognostic significance of miR-194 in endometrial cancer

Endometrial cancer (EC) is the leading malignant tumor occurring in the female genital tract and some subtypes are highly invasive and metastatic. miRNAs are small non-coding RNAs that have a broad impact on cancer progression. In particular, miR-194 regulates epithelial to mesenchymal transition (EMT) by suppressing the expression of BMI-1 in EC. In this retrospective study, the clinical significance of miR-194 was investigated in archival EC specimens. We extracted total RNA from thirty-two EC samples and quantified the expression level of miR-194. We discovered that the expression level of miR-194 was significantly (P = 0.03) lower in type I EC patients with more advanced stage. In addition, patients with higher miR-194 levels have better prognosis than those with lower miR-194 levels (P = 0.0067; Cut-off value of miR-194 = 0.3). These results indicate that miR-194 has potential to serve as prognostic biomarker for EC patients.

Citation Format: Haiyan Zhai, Mihriban Karaayvaz, Peixin Dong, Noriaki Sakuragi, Jingfang Ju. Prognostic significance of miR-194 in endometrial cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5293. doi:10.1158/1538-7445.AM2013-5293

True total-tract digestibility of phosphorus in corn and soybean meal for fifteen-kilogram pigs are additive in corn-soybean meal diet

The objective of this study was to verify the additivity of true total-tract P digestibility (TPD) in corn and soybean meal (SBM) for 15-kg pigs. Fifty-four barrows with an average initial BW of 14.7±1.6 kg were used in a randomized complete block design with a 3×2 factorial arrangement of 6 diets. Three P sources included corn, SBM, and their mixture at a ratio of 2:1. Each P source was provided at low or high level. The diets were fed for a 5-d adjustment period followed by a total collection period of 7 d with ferric oxide as a marker to determine the initiation and termination of fecal collection. The results showed the high P level of each P source increased (P<0.001) P intake, fecal P output, and digested P compared with the low P level. The respective apparent total-tract digestibility of P were 35.66 and 40.57% for low and high P levels in corn, 35.72 and 38.04% for low and high P levels in SBM, and 41.85 and 38.53% for low and high P levels in the corn-soybean meal mixture without significant difference between P levels within P sources. Regressing daily digested P against daily P intake, the TPD was estimated at 40.53, 35.96, and 37.52% for corn, SBM, and their mixture, respectively. The expected TPD in corn and SBM mixture was calculated to be 37.92% based upon the P contribution coefficient calculated to be 0.428 for corn and 0.572 for SBM. The determined TPD (37.52%) in the mixture was not statistically different from the expected (37.92%). In conclusion, the TPD in corn and SBM are additive in corn-soybean meal diet for pigs.